Anthropic Blocks Claude Accounts After Finding Five Biology Misuse Cases

Anthropic says it identified five cases in which Claude was used for biological research with potential biological-weapons applications, then banned the associated accounts. The company says the cases show what its models can assist with, while stopping short of finding that the scientists intended harm or developed a weapon.

The cases were disclosed in Anthropic’s misuse report. One involved a scientist seeking Claude’s help with a grant application for gain-of-function research on chikungunya. According to Anthropic, the proposal aimed to identify mutations that affect the virus’s transmissibility and ability to evade immune responses, then engineer those changes into the virus.

One case captures the dual-use dilemma

Anthropic said the chikungunya work could have legitimate medical applications, including vaccine and therapeutic development. But it considered the case more concerning because the research was intended for a military research institute. The company did not identify the scientists and said it could not establish whether the research was meant to be weaponized.

Capability evidence, not proof of a weapon

Anthropic says the cases provide evidence of model capability, but do not concretely demonstrate that the capability was used to develop biological weapons in the real world. It also said it could not assert that the scientists involved intended harm. The distinction is material: biology research can produce information useful for treatments and for harmful applications.

The response moves from accounts to controls

Anthropic said it acted after detecting and investigating the cases. Its response combines account enforcement with changes intended to improve how it prevents, detects and disrupts similar activity.

• It banned the identified users’ accounts.
• It incorporated investigative findings into safeguards, enforcement and threat-intelligence processes.
• It said newer models, including Claude Fable 5, restrict a wide range of dual-use biology queries.

That creates a difficult operational choice for AI companies. A system designed to flag potentially harmful biology assistance must act amid scientific ambiguity, while researchers working on legitimate medical questions may face restrictions. Anthropic’s report shows where it drew that line in these five cases; its safeguards are now part of the response.